nutritional priorities to support glp-1 therapy for obesity glp 1 nutrition guidelines obesity: a joint Advisory Nutritional priorities to support GLP‐1

When Ozempic and Wegovy were in short supply, compounded semaglutide became a vital option for people struggling with obesity and type 2 diabetes

Journal of Clinical Endocrinology and Metabolism 2001;86:1853-1860

2022;11(1): e022761

Geraci MJ , McCoy SL , Aquino ME

Two phase II trials - one in a population with obesity (without T2D) [45], and a second in a population with T2D and overweight/obesity [46], have recently been published and their key findings are presented below (Table 1)

This article provides insights into FDA-approved oral and injectable GLP-1 and combined GLP-1/GIP medications, their benefits, and typical dosages